"The weight loss jabs Ozempic, Mounjaro and Wegovy - a type of medicine containing semaglutide - are increasingly being seen as a medical wonder of the age. They bring great benefits to people with diabetes and obesity."
"They reduce sugar in the blood (the key feature of diabetes), but also decrease appetite and slow down digestion, both of which result in weight loss as people eat less."
Semaglutide-based medications including Ozempic, Mounjaro, and Wegovy are increasingly recognized as significant medical advances for treating diabetes and obesity. These medications work through multiple mechanisms: they reduce blood sugar levels, which addresses the core issue in diabetes, while simultaneously decreasing appetite and slowing digestive processes. These combined effects lead to weight loss as patients consume less food. While one study has raised concerns about potential side effects, more recent and encouraging research has emerged regarding semaglutide's relationship with addiction, suggesting the overall safety and benefit profile may be more favorable than initially questioned.
#semaglutide #weight-loss-medications #diabetes-treatment #obesity-management #medication-side-effects
Read at Independent
Unable to calculate read time
Collection
[
|
...
]